These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 9610941)
1. Characterization of delta9-tetrahydrocannabinol and anandamide antinociception in nonarthritic and arthritic rats. Smith FL; Fujimori K; Lowe J; Welch SP Pharmacol Biochem Behav; 1998 May; 60(1):183-91. PubMed ID: 9610941 [TBL] [Abstract][Full Text] [Related]
2. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat. Cox ML; Welch SP Eur J Pharmacol; 2004 Jun; 493(1-3):65-74. PubMed ID: 15189765 [TBL] [Abstract][Full Text] [Related]
3. The cannabinoid CB1 receptor antagonist SR141716A attenuates the memory impairment produced by delta9-tetrahydrocannabinol or anandamide. Mallet PE; Beninger RJ Psychopharmacology (Berl); 1998 Nov; 140(1):11-9. PubMed ID: 9862397 [TBL] [Abstract][Full Text] [Related]
4. The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor. Cox ML; Haller VL; Welch SP Eur J Pharmacol; 2007 Sep; 570(1-3):50-6. PubMed ID: 17588560 [TBL] [Abstract][Full Text] [Related]
5. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics. Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167 [TBL] [Abstract][Full Text] [Related]
6. Anandamide- and delta9-tetrahydrocannabinol-evoked arachidonic acid mobilization and blockade by SR141716A [N-(Piperidin-1-yl)-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4 -methyl-1H-pyrazole-3-carboximide hydrochloride]. Shivachar AC; Martin BR; Ellis EF Biochem Pharmacol; 1996 Mar; 51(5):669-76. PubMed ID: 8615904 [TBL] [Abstract][Full Text] [Related]
7. Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A. Welch SP; Huffman JW; Lowe J J Pharmacol Exp Ther; 1998 Sep; 286(3):1301-8. PubMed ID: 9732392 [TBL] [Abstract][Full Text] [Related]
8. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Järbe TU; Lamb RJ; Lin S; Makriyannis A Psychopharmacology (Berl); 2001 Aug; 156(4):369-80. PubMed ID: 11498713 [TBL] [Abstract][Full Text] [Related]
9. Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Delta(9)-THC and anandamide. Houser SJ; Eads M; Embrey JP; Welch SP Brain Res; 2000 Feb; 857(1-2):337-42. PubMed ID: 10700588 [TBL] [Abstract][Full Text] [Related]
11. Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception. Welch SP; Dunlow LD; Patrick GS; Razdan RK J Pharmacol Exp Ther; 1995 Jun; 273(3):1235-44. PubMed ID: 7791096 [TBL] [Abstract][Full Text] [Related]
12. Assessment of anandamide interaction with the cannabinoid brain receptor: SR 141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. Adams IB; Compton DR; Martin BR J Pharmacol Exp Ther; 1998 Mar; 284(3):1209-17. PubMed ID: 9495885 [TBL] [Abstract][Full Text] [Related]
13. Anandamide induces overeating: mediation by central cannabinoid (CB1) receptors. Williams CM; Kirkham TC Psychopharmacology (Berl); 1999 Apr; 143(3):315-7. PubMed ID: 10353436 [TBL] [Abstract][Full Text] [Related]
14. Sex differences in cannabinoid 1 vs. cannabinoid 2 receptor-selective antagonism of antinociception produced by delta9-tetrahydrocannabinol and CP55,940 in the rat. Craft RM; Wakley AA; Tsutsui KT; Laggart JD J Pharmacol Exp Ther; 2012 Mar; 340(3):787-800. PubMed ID: 22182934 [TBL] [Abstract][Full Text] [Related]
15. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta9-tetrahydrocannabinol. McMahon LR Psychopharmacology (Berl); 2009 Apr; 203(2):219-28. PubMed ID: 18592221 [TBL] [Abstract][Full Text] [Related]
17. Changes in rat brain cannabinoid binding sites after acute or chronic exposure to their endogenous agonist, anandamide, or to delta 9-tetrahydrocannabinol. Romero J; García L; Fernández-Ruiz JJ; Cebeira M; Ramos JA Pharmacol Biochem Behav; 1995 Aug; 51(4):731-7. PubMed ID: 7675852 [TBL] [Abstract][Full Text] [Related]
18. Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration. Anikwue R; Huffman JW; Martin ZL; Welch SP J Pharmacol Exp Ther; 2002 Oct; 303(1):340-6. PubMed ID: 12235269 [TBL] [Abstract][Full Text] [Related]
19. Hemodynamic effects of cannabinoids: coronary and cerebral vasodilation mediated by cannabinoid CB(1) receptors. Wagner JA; Járai Z; Bátkai S; Kunos G Eur J Pharmacol; 2001 Jul; 423(2-3):203-10. PubMed ID: 11448486 [TBL] [Abstract][Full Text] [Related]
20. Two distinctive antinociceptive systems in rats with pathological pain. Mao J; Price DD; Lu J; Keniston L; Mayer DJ Neurosci Lett; 2000 Feb; 280(1):13-6. PubMed ID: 10696800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]